Ronald Drengler
- Oncology top 5%
- Cancer Treatment and Pharmacology 13
- Colorectal Cancer Treatments and Studies 7
- Pancreatic and Hepatic Oncology Research 5
- Lung Cancer Research Studies 4
- Drug Transport and Resistance Mechanisms 3
- Neutropenia and Cancer Infections 3
- Pharmacology top 10%
-
- Cancer therapeutics and mechanisms 8
-
- Cancer Research and Treatments 3
- Co-authors
- Daniel D. Von HoffEric K. RowinskyMaura A. KraynakMiguel A. Villalona‐CaleroJohn G. KuhnLisa A. HammondLon SmithJoseph Stephenson
- Cited by
- OncologyPharmacologyGenetics
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Ronald Drengler
27 papers receiving 686 citations
Peers
Comparison fields: 5 of 73
- Oncology 487
- Pharmacology 55
- Genetics 56
- Cancer Research 70
- Molecular Biology 296
Countries citing papers authored by Ronald Drengler
This map shows the geographic impact of Ronald Drengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Drengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Drengler more than expected).
Fields of papers citing papers by Ronald Drengler
This network shows the impact of papers produced by Ronald Drengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Drengler. The network helps show where Ronald Drengler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ronald Drengler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 66 | |
| 2 | 2011 | 4 | |
| 3 | 2008 | 7 | |
| 4 | 2008 | 5 | |
| 5 | 2008 | 2 | |
| 6 | 2006 | 7 | |
| 7 | 2005 | 19 | |
| 8 | 2004 | 19 | |
| 9 | 2000 | 12 | |
| 10 | 2000 | 37 | |
| 11 | Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel. | 2000 | 36 |
| 12 | 1999 | 55 | |
| 13 | 1999 | 69 | |
| 14 | A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies. | 1999 | 2 |
| 15 | A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors. | 1999 | 4 |
| 16 | 1999 | 85 | |
| 17 | 1998 | 30 | |
| 18 | 1998 | 114 | |
| 19 | Docetaxel in combination with fluorouracil: study design and preliminary results. | 1997 | 1 |
| 20 | New anticancer agents in clinical development. | 1995 | 9 |
About Ronald Drengler
Ronald Drengler is a scholar working on Oncology, Biotechnology and Behavioral Neuroscience, having authored 27 papers that have together received 701 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Cancer therapeutics and mechanisms (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Lung Cancer Research Studies (4 papers), Cancer Research and Treatments (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Oncology (487 citations), Pharmacology (55 citations) and Genetics (56 citations). Ronald Drengler has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Daniel D. Von Hoff, Eric K. Rowinsky, Maura A. Kraynak, Miguel A. Villalona‐Calero, John G. Kuhn, Lisa A. Hammond, Lon Smith, Joseph Stephenson, Geoffrey R. Weiss and S. Gail Eckhardt. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.